| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.400 | None | 0.961 | 3 | 0 | 1994 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.980 | 3 | 0 | 1985 | 2019 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2009 | 2020 | |||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 1995 | 2020 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
breast cancer anti-estrogen resistance 4 | 0.653 | 0.346 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2019 | |||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.987 | 2 | 0 | 2001 | 2019 | ||||||||
|
H2A.X variant histone | 0.484 | 0.808 | 0.18 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.400 | None | 0.875 | 2 | 0 | 1995 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.976 | 2 | 0 | 1999 | 2020 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.400 | None | 0.939 | 2 | 0 | 1985 | 2020 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.919 | 2 | 0 | 1994 | 2019 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.360 | None | 1.000 | 2 | 0 | 2004 | 2016 | ||||||||
|
uridine monophosphate synthetase | 0.584 | 0.615 | 1.1E-04 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2014 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.600 | None | 0.955 | 2 | 0 | 1986 | 2020 | ||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
disease | 0.400 | None | 0.946 | 2 | 0 | 2000 | 2019 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.952 | 2 | 0 | 1993 | 2019 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1999 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.980 | 2 | 0 | 1997 | 2019 | ||||||||
|
hes family bHLH transcription factor 1 | 0.468 | 0.885 | 0.71 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
DNA methyltransferase 3 beta | 0.453 | 0.846 | 0.20 |
|
disease | 0.400 | None | 0.882 | 2 | 0 | 2003 | 2019 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.400 | None | 0.944 | 2 | 0 | 2001 | 2019 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 2003 | 2020 |